ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 118 filers reported holding ATEA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $46,233 | -19.6% | 15,411 | +0.3% | 0.00% | – |
| Q2 2023 | $57,469 | +16.2% | 15,366 | +4.1% | 0.00% | – |
| Q1 2023 | $49,443 | -38.5% | 14,759 | -11.7% | 0.00% | – |
| Q4 2022 | $80,361 | -8.7% | 16,707 | +8.4% | 0.00% | – |
| Q3 2022 | $88,000 | -18.5% | 15,416 | +2.4% | 0.00% | – |
| Q2 2022 | $108,000 | -28.0% | 15,055 | -27.3% | 0.00% | – |
| Q1 2022 | $150,000 | -35.1% | 20,721 | -19.8% | 0.00% | – |
| Q4 2021 | $231,000 | -20.3% | 25,825 | +212.1% | 0.00% | -100.0% |
| Q3 2021 | $290,000 | -21.6% | 8,274 | -51.9% | 0.00% | 0.0% |
| Q2 2021 | $370,000 | +45.7% | 17,203 | +319.0% | 0.00% | 0.0% |
| Q1 2021 | $254,000 | – | 4,106 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tyrus Capital S.A.M. | 1,260,000 | $3,780,000 | 35.90% |
| BML Capital Management, LLC | 4,800,000 | $14,400,000 | 13.22% |
| Stonepine Capital Management, LLC | 1,720,000 | $5,160,000 | 1.71% |
| TANG CAPITAL MANAGEMENT LLC | 3,600,000 | $10,800,000 | 1.52% |
| CM Management, LLC | 275,000 | $825,000 | 0.88% |
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $7,456,914 | 0.83% |
| EcoR1 Capital, LLC | 6,995,861 | $20,987,583 | 0.71% |
| SECTORAL ASSET MANAGEMENT INC | 600,461 | $1,801,383 | 0.35% |
| Newtyn Management, LLC | 400,000 | $1,200,000 | 0.30% |
| Diametric Capital, LP | 200,000 | $600,000 | 0.25% |